Flucytosine‐based prodrug activation by cold physical plasma
Sign Up to like & getrecommendations! Published in 2022 at "Archiv der Pharmazie"
DOI: 10.1002/ardp.202200061
Abstract: Reactive oxygen species (ROS) are known to trigger drug release from arylboronate‐containing ROS‐responsive prodrugs. In cancer cells, elevated levels of ROS can be exploited for the selective activation of prodrugs via Baeyer–Villiger type oxidation rearrangement… read more here.
Keywords: physical plasma; cold physical; flucytosine based; prodrug activation ... See more keywords